Sofradim Production has a total of 1145 patents globally, out of which 709 have been granted. Of these 1145 patents, more than 45% patents are active. The United States of America is where Sofradim Production has filed the maximum number of patents, followed by Europe (EPO) and Germany. Parallelly, France seems to be the main focused R&D center and also France is the origin country of Sofradim Production.
Sofradim Production is the subpart of Covidien was founded in the year 1999. The Company manufactures and researches medical instruments and apparatuses.
Do read about some of the most popular patents of Sofradim Production which have been covered by us in this article and also you can find Sofradim Production patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Sofradim Production patent portfolio.
How many patents does Sofradim Production have?
Sofradim Production has a total of 1145 patents globally. These patents belong to 261 unique patent families. Out of 1145 patents, 517 patents are active.
How Many Patents did Sofradim Production File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Sofradim Production Applications Filed | Sofradim Production Patents Granted |
2023 | 1 | 17 |
2022 | 12 | 33 |
2021 | 17 | 24 |
2020 | 19 | 43 |
2019 | 26 | 50 |
2018 | 29 | 43 |
2017 | 27 | 58 |
2016 | 36 | 73 |
2015 | 76 | 67 |
2014 | 40 | 56 |
2013 | 66 | 34 |
2012 | 114 | 32 |
2011 | 75 | 17 |
How many Sofradim Production patents are Alive/Dead?
Worldwide Patents
How Many Patents did Sofradim Production File in Different Countries?
Countries in which Sofradim Production Filed Patents
Country | Patents |
United States Of America | 226 |
Europe | 155 |
Germany | 124 |
Austria | 116 |
Australia | 110 |
Canada | 88 |
France | 71 |
Japan | 50 |
China | 37 |
Spain | 36 |
Hong Kong (S.A.R.) | 4 |
Italy | 4 |
United Kingdom | 3 |
India | 2 |
Denmark | 1 |
New Zealand | 1 |
Brazil | 1 |
Ireland | 1 |
Portugal | 1 |
Turkey | 1 |
Where are Research Centers of Sofradim Production Patents Located?
10 Best Sofradim Production Patents
US7833234B2 is the most popular patent in the Sofradim Production portfolio. It has received 1124 citations so far from companies like Ethicon, Applied Medical Resources Corporation, and Cilag Gmbh International.
Below is the list of 10 most cited patents of Sofradim Production:
Publication Number | Citation Count |
US7833234B2 | 1124 |
US20090004455A1 | 1062 |
US9119898B2 | 769 |
US8142515B2 | 758 |
US6547801B1 | 525 |
US6779701B2 | 298 |
US6575897B1 | 273 |
US20030036676A1 | 252 |
US6596002B2 | 241 |
US6692506B1 | 222 |
How many inventions of other companies were rejected due to Sofradim Production patents?
The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Sofradim Production invention. They couldn’t because Sofradim Production had protected those before them.
Examiners at the USPTO referred 59 Sofradim Production patents in 264 rejections (35 USC § 102 or 35 USC § 103 types).
The top citing companies in the Sofradim Production patent portfolio are Boston Scientific Scimed Inc, Coloplast and C R Bard.
List of the Companies whose Patents were rejected citing Sofradim Production –
Company | Number of Patent Applications that faced Rejection Citing Sofradim Production Patents | Number of Rejections (102 & 103) |
Boston Scientific Scimed Inc | 11 | 22 |
Coloplast A/S | 8 | 9 |
C R Bard | 6 | 9 |
Ethicon | 6 | 9 |
Smith & Nephew | 5 | 14 |
Edwards Lifesciences | 3 | 22 |
Midcap Financial Trust | 2 | 3 |
Innovatus Life Sciences Lending Fund I Lp | 2 | 6 |
Bvw Holding Ag | 2 | 3 |
Terumo Kabushiki Kaisha | 2 | 4 |
Count of 102 and 103 Type Rejections based on Sofradim Production Patents
Top Sofradim Production Patents used in Rejecting Most Patent Applications
Patent Number | Count of Rejected Applications |
US8933290B2 | 11 |
US6971252B2 | 8 |
US6685629B2 | 6 |
US9242026B2 | 5 |
US7819897B2 | 5 |
US9039979B2 | 4 |
US6695855B1 | 4 |
US7662087B2 | 4 |
US8968762B2 | 3 |
US8808315B2 | 3 |
US9272073B2 | 3 |
US20050125014A1 | 3 |
US8932619B2 | 3 |
US20090036907A1 | 3 |
US9119898B2 | 3 |
What Percentage of Sofradim Production US Patent Applications were Granted?
Sofradim Production (Excluding its subsidiaries) has filed 233 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 174 have been granted leading to a grant rate of 87.8%.
Below are the key stats of Sofradim Production patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Sofradim Production?
Law Firm | Total Applications | Success Rate |
Covidien Lp | 188 | 88.05% |
Oliff Plc | 26 | 90.48% |
Oliff & Berridge | 7 | 100.00% |
Carter Deluca & Farrell Llp | 3 | 66.67% |
Peter Deluca | 3 | 33.33% |
Kilpatrick Townsend & Stockton Llp | 2 | 100.00% |
Rothwell Figg Ernst & Manbeck Pc | 2 | 100.00% |
Fletcher Yoder | 1 | 0% |
Wagenknecht Ip Law Group Pc | 1 | 100.00% |
What are Sofradim Production key innovation segments?
What Technologies are Covered by Sofradim Production?
The chart below distributes patents filed by Sofradim Production